RT @superkalifragi4: @jeha2019 @nouripour @Tagesspiegel Scheinbar nach dem Motto „if you go through hell keep on going“. Das jemand das bei…
@jeha2019 @nouripour @Tagesspiegel Scheinbar nach dem Motto „if you go through hell keep on going“. Das jemand das bei dem aktuellen Stand noch sagen kann… absurd, ignorant und ja, vielleicht sogar dumm! Das wurde schon 2020 vermutet: https://t.co/hADdmBoi
@OttawaCitizen The vaccines nano particles breach the blood brain barrier. Once crossed, its aluminum adjuvants spike and multiply themselves on the brain, therefore damaging the brain thanks to its metals which can and will lead to many having dementia/Pa
RT @agvBruceAdams: Here is the article. https://t.co/UzU52yClkL
RT @agvBruceAdams: Here is the article. https://t.co/UzU52yClkL
RT @agvBruceAdams: Here is the article. https://t.co/UzU52yClkL
RT @agvBruceAdams: Here is the article. https://t.co/UzU52yClkL
RT @agvBruceAdams: Here is the article. https://t.co/UzU52yClkL
Here is the article. https://t.co/UzU52yClkL
@TheRealMo777 @MikeCubfan @RepThomasMassie Just saying on and on the vaccines are "safe" doesn't reflect every concern. Informed consent. https://t.co/TglW5wCutL
Also, how did they rectify this issue? https://t.co/FBWtEiDT7h
Sars page 28 nr 10 https://t.co/uDo1hKxOGn
@VaccineWatch それはワクチンの場合はウイルスとは異なり、BBBを通過しないとかそういうことなんでしょうか? 自分なりに調べて見ましたが、全く分からず。。。 https://t.co/4EYP58JRmR
Sars from the bottom up https://t.co/uDo1hKxOGn
Last but not least Sars 8 https://t.co/uDo1hKxOGn
«The recent use of Aluminium nanoparticles in vaccines are reported to cross blood-brain barrier and harm the brain cells because of molecular mimicry.» Fuentes: https://t.co/BiKk4W4JNs https://t.co/omBAXZnLkN
RT @vegsource: Interesting: “recent use of Aluminium nanoparticles in vaccines reported to cross blood-brain barrier & harm the brain cells…
RT @vegsource: Interesting: “recent use of Aluminium nanoparticles in vaccines reported to cross blood-brain barrier & harm the brain cells…
Fascinating read on #COVID19 vaccines in Nov #cmaj https://t.co/1YPvewqvNX Then I see pub date Aug 24, and only 2 citations (who should get vaccine first), and I realize the huge challenge of traditional scientific process in rapidly addressing concerns du
Sars Vaccine https://t.co/uDo1hKxOGn
Sars 2 vaccine https://t.co/uDo1hKgdhN
(CMAJ) Los retos en la evaluación de vacunas para SARS-CoV-2: hay que considerar factores cambiantes como los niveles de exposición al virus, inmunidad de la población y prácticas de distanciamiento social. Ojo también a la evaluación postcomercialización
RT @RevistaMFSamfyc: Retos para evaluar las vacunas de SARS-CoV-2 durante la pandemia de COVID-19 https://t.co/QC2QoCACus PMID 32646869
Retos para evaluar las vacunas de SARS-CoV-2 durante la pandemia de COVID-19 https://t.co/QC2QoCACus PMID 32646869
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic – via @CMAJ https://t.co/PrfT8skNwr
Sars Coronavirus 2 https://t.co/uDo1hKxOGn
RT @rincondesisifo: (CMAJ) Retos en la evaluación de la seguridad y eficacia de las vacunas para el #COVID19 https://t.co/LeQZVTWVLo Revisi…
RT @ActionOnSepsis: Vaccinations are key to preventing infections and reducing the burden of sepsis. In a recent @CMAJ analysis, Drs Abu-Ra…
Vaccinations are key to preventing infections and reducing the burden of sepsis. In a recent @CMAJ analysis, Drs Abu-Ray, Gantt, and Sadarangani discuss the challenges in evaluating a vaccine for COVID-19: https://t.co/lHQvkmNLCI @VEC_ubc @manishs_
An interesting article on evaluating vaccines to prevent #COVID19 in Canada's major medical journal @BCChildrensHosp @BCCHresearch
(CMAJ) Retos en la evaluación de la seguridad y eficacia de las vacunas para el #COVID19 https://t.co/LeQZVTWVLo Revisión https://t.co/FXvLCs4O7V
A new analysis article discusses the many challenges in evaluating #SARSCoV2 vaccines such as variations in exposure, population immunity and local social distancing practices. @manishs_ @VEC_ubc #COVID19 https://t.co/6viv8jZ6fL https://t.co/DlbJcAdZtw
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic---https://t.co/6BJNSpoJvw
A safe and effective vaccine for SARS-CoV-2 is desperately needed and wanted. This article in @CMAJ discusses some of the considerations when developing a vaccine https://t.co/afs7Z2P9aw #vaccines #COVID19 @picardonhealth @CPHO_Canada @theresaboyle